Bone Health Technologies, Inc.

Bone Health Technologies, Inc. is a medical technology company focused on developing non-pharmacological solutions to improve bone health and reduce fractures. Their flagship product, Osteoboost, is the first FDA-cleared prescription medical device for the treatment of osteopenia in postmenopausal women. Osteoboost is a wearable belt that delivers targeted, low-amplitude, high-frequency vibrations to the spine and hips, stimulating the body's natural bone remodeling process to reduce bone density loss.

The company is backed by a strong team of medical experts and investors, and they are committed to bringing their innovative solutions to market. Their vision is to empower people to lead longer, stronger, and more active lives by safeguarding bone density from the effects of aging, menopause, cancer, and other degenerative causes of bone loss. Osteoboost is expected to be available for preorder in late 2024.

Bone Health Technologies, Inc. is dedicated to developing innovative solutions to combat osteoporosis and osteopenia. Their mission is to empower individuals to live longer, stronger, and more active lives by safeguarding bone density from the effects of menopause, aging, cancer, and other degenerative causes of bone loss. Their first holistic bone health solution, Osteoboost, is FDA-cleared to treat osteopenia in postmenopausal women and is expected to ship in late 2024.

Bone Health Technologies, Inc. promotes a culture of innovation, collaboration, and patient-centricity. They are driven by a passion to revolutionize bone health and empower people to live longer, stronger lives. The company emphasizes the importance of scientific rigor and evidence-based solutions, while fostering a supportive and inclusive environment where diverse perspectives are valued. They prioritize strong teamwork, open communication, and a shared commitment to making a meaningful difference in the lives of their patients.